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1496 The Journal of Thoracic and CardObjectives: We sought to evaluate the contribution of unifocalization procedures in
the management of patients with pulmonary atresia, ventricular septal defect, and
major aortopulmonary collateral arteries.
Methods: From 1975 through 1995, 82 consecutive patients were entered in a
multistage approach and had 189 sternotomies and thoracotomies to perform 119
shunts, 130 major aortopulmonary collateral artery transplantations, and 76 major
aortopulmonary collateral artery ligations. The serial angiographies and the follow-up
of these patients were reviewed.
Results: The concurrent follow-up rate was 80%. The hospital mortality of the
preliminary procedures was 4% (7/189). Fifty-three (65%) patients had a complete
repair. The hospital mortality of the repair was 8% (4/53), and 9 late deaths occurred
after repair, all of which were cardiac related. The overall survival of all patients to the
age of 30 years was 58%  7%. Survival 12 years after complete repair was 51% 
14%. On angiography, central shunts promoted growth of central pulmonary arteries
in all cases (29 patients). Sixty unifocalized major aortopulmonary collateral arteries
were identified in 31 patients. After a mean of 3.2  4 years, 26 thrombosed, and
12 presented with a stenosis of greater than 50%. Serial measurements of 29 major
aortopulmonary collateral arteries showed no signs of growth (P  .25).
Conclusion: Long-term survival into adulthood of patients with pulmonary atresia,
ventricular septal defect, and major aortopulmonary collateral arteries has been
achieved with a multistage approach. However, late survival depends exclusively on
the growth of the native pulmonary circulation. The few unifocalized major aorto-
pulmonary collateral arteries that did not thrombose failed to grow.
Until recently, the outcomes of patients born with pulmonary atresia, ven-tricular septal defect (VSD), and major aortopulmonary collateral arteries(MAPCAs) were extremely grim. In the early surgical era, these patients
had only a 20% chance of being alive at the age of 30 years.1 Despite numbers of
enthusiastic reports from different surgical teams, there is only scarce evidence that
surgical management of these patients has resulted in any improvement in their
long-term outcomes. The published data are limited to surgical series with maximal
follow-up of 10 years.2-4
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DIn the early 1980s, a policy of multistage operations to
achieve a complete repair of these lesions was initiated in
Melbourne by Dr R. B. Mee and later followed by Drs W. J.
Brawn and T. R. Karl.5 These operations consisted of pre-
paratory procedures consisting of central shunting and uni-
focalization of MAPCAs with native pulmonary artery (PA)
branches performed by multiple sternotomies and thoracot-
omies. Once a reasonable pulmonary vascularization had
been obtained in these patients, they were offered a com-
plete repair with transventricular closure of the VSD and
implantation of a valved conduit between the right ventricle
and the PA. We reviewed the long-term outcome of the
patients who underwent this multistage approach.
Patients and Methods
The design of the study was submitted and approved by the
hospital ethics committee. The data of all patients with pulmonary
atresia, VSD, and MAPCAs who took part in the policy of staged
repair in the Royal Children’s Hospital, Melbourne, between Jan-
uary 1979 and May 1995 were reviewed. To evaluate the fate of
the patients born with MAPCA-dependent lung circulation, we
excluded those patients with ductus-dependent circulation and
those with tetralogy of Fallot who had PAs of reasonable size.
Eighty-four patients were offered surgical intervention. Two
patients who had exploratory median sternotomies during which
no central PA could be found were offered no further treatment.
The remaining 82 patients constitute the core of this study. The
characteristics of the patients before the first operation are given in
Table 1.
The patients underwent 67 sternotomies, 61 right thoracoto-
mies, and 61 left thoracotomies to perform the preparatory proce-
dures described in Table 2. The median age at the time of the first
operation was 1.4 years (range, 7 days to 34 years). Nineteen
patients had only one procedure, and the remaining had a mean of
2.6  0.8 procedures during a median time interval of 1.6 years
(range, same day to 10 years later).
The last follow-up of the patients was obtained from their
referring cardiologists. Angiograms were reviewed several times
to identify the effect of the different procedures performed on PA
growth. Because of the diversity of the operations, attention was
focused on the results of 3 standard procedures: central shunt,
MAPCA transplantation, and PA patch enlargement. When the left
PA or a transplanted MAPCA could be identified on serial exam-
inations, their caliber and the size of a 1-cm mark displayed on the
grid filmed at the time of the angiogram were measured. Care was
Abbreviations and Acronyms
LV  left ventricular
MAPCAmajor aortopulmonary collateral artery
PA  pulmonary artery
RV  right ventricular
TOF  tetralogy of Fallot
VSD  ventricular septal defecttaken to measure each MAPCA of a given patient at a similar level
The Journal of Thoracicdevoid of focal stenosis. The absolute size of the vessels was then
calculated by dividing the measurement of the vessel by the
measurement of the 1-cm mark.
Survival analysis was performed by the Kaplan-Meier method
for the whole patient group and separately for those patients who
reached full repair and those who received “palliative surgery.”
Survival curves were compared by the log-rank test.
The measured PA and MAPCA diameters were compared with
paired t tests. An analysis of prognostic or risk factors for survival
or death was performed by logistic regression, with initial univar-
iate and subsequent multivariate analysis. A Cox proportional
hazards analysis was performed for the same prognostic factors
and survival time. These 2 analyses were performed for the total
patient group (n  82) and also for those who reached full repair
(n  53).
The prognostic factors included in the analysis were sex, symp-
tomatic status, age at the time of the first operation, arterial oxygen
TABLE 1. Patient characteristics
No. of patients 82
Sex (male/female) 51/31
Symptoms
Asymptomatic 4
Cyanosis 48
Heart failure 10
Cyanosis  heart failure 18
Unknown 3
Mean arterial saturation* 81% 9%
Patients with no confluent PAs* 9
Mean no. of MAPCAs per patient 4 1.4
PA, Pulmonary artery; MAPCAs, major aortopulmonary collateral arteries.
*Data obtained during catheterization.
TABLE 2. Preparatory procedures
Procedures No.
Central shunt
MPA implantation 35
Polytetrafluoroethylene conduit 16
RVOT patch 5
RV-to-PA conduit 7
Right modified BT shunt 17
Left modified BT shunt 14
Shunt from aorta to PA 9
PA patch enlargement 13
Shunt to MAPCAs 16
MAPCAs transplantation 130
MAPCAs ligation 76
Azygos vein interposition 9
Pericardial roll PA creation 9
Mitral valve repair 1
Right upper lobe bronchus resection 1
MPA, Main pulmonary artery; RVOT, right ventricular outflow tract; RV,
right ventricle; PA, pulmonary artery; BT shunt, Blalock-Taussig shunt;
MAPCAs, major aortopulmonary collateral arteries.
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Dsaturation, the presence of confluent PAs, the number of MAPCAs,
the performance of a central shunt or a peripheral shunt, age at full
repair, total number of operations, right ventricular (RV) systolic
pressure at late follow-up, and PA pressure at follow-up.
The analyses were performed with Stata version 8 software
(Stata Corp, College Station, Tex).
Results
Procedural Outcome
The hospital mortality of the preparatory procedures was
4% (7 patients). Two patients died of pulmonary hemor-
rhage, and 1 died of bleeding related to the rupture of a suture
line of a conduit between the right ventricle and the PA. Four
patients aged 2, 12, 14, and 17 months, respectively, died of the
consequences of hypoxia after either central shunts or unifo-
calizations. One patient went into heart failure after unifo-
calization and underwent a successful early repair 3 days
after that procedure. The condition of 22 patients was
deemed unrepairable after the last palliative procedure.
Complete repair was achieved in 53 patients at a median
of 9 months (range, same day to 5 years later) after the last
preparatory procedure. The median age at the time of the
repair was 4 years (range, 3 months to 35 years). The repair
consisted of a transventricular patch closure of the VSD and
the placement of a conduit between the ventriculotomy and
the main PA. The conduits used were homografts (n  23),
bioprosthetic valved conduits (n  28), and mechanical
valves with patches (n 2). Additionally, 5 MAPCAs were
transplanted and 2 were ligated, and 6 right and 1 left PAs
underwent patch enlargement. Four patients had patch en-
largement of both PAs, and 1 patient underwent a recon-
struction of both central PAs with a pericardial roll. One
Figure 1. Kaplan-Meier curve of survival since birth of all patients.patient was left with a fenestrated VSD, which was subse-
1498 The Journal of Thoracic and Cardiovascular Surgery ● Decquently closed during the same hospital stay. The hospital
mortality of the repair was 8% (4 patients). Two infants died
of respiratory failure related to severe bronchomalacia. One
patient who maintained suprasystemic RV pressures died
during a pulmonary hypertensive crisis, and the last patient
died from uncontrollable bleeding from the right upper lobe
bronchus.
Follow-up
The concurrent follow-up rate (2003-2004) was 80%. The
median follow-up time was 14.2 years (range, 3 months to
25 years), for a total of 967 patient-years. Seven of the 22
patients whose condition was believed to be unrepairable
died a median of 8 years (range, 3 months to 13 years) after
the last procedure. The cause of death was hemoptysis (n 
2), hypoxia (n  1), endocarditis (n  1), pulmonary
hemorrhage related to the rupture of PA during an interven-
tional catheterization procedure (n  1), and unknown (n 
2). One patient was lost to follow-up. One patient under-
went heart-lung transplantation 9 years after the last pallia-
tive procedure and was still alive 14 years after the trans-
plantation. The remaining palliated patients were still alive
after a median of 13 years (range, 9-25 years). At last
follow-up, 1 patient was in New York Heart Association
class I, 8 were in class II, and 4 were in class III.
Two of the patients who underwent a complete repair
were lost to follow-up. Nine late deaths occurred a median
of 4 years (range, 4 months to 21 years) after repair. Four
patients died of RV failure, 2 patients had a sudden death
(one of whom was known to have pulmonary hypertension),
and 2 patients died after reoperations (1 for tracheal stenosis
and 1 for homograft replacement). The cause of death could
Figure 2. Kaplan-Meier curves of survival since first procedure.not be determined in 1 patient. The clinical status of 1 living
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Dpatient could not be ascertained. Twenty-five (66%) of the
remaining 38 patients were in New York Heart Association
class I, 11 (29%) were in class II, and 1 was in class III.
Sixty-nine percent (9/13) of the palliated patients and 96%
(29/30) of the repaired patients worked or studied. None of
the palliated patients practiced sport, whereas 57% (16/28)
of the repaired ones engaged in regular sporting activities.
The Kaplan-Meier curve of survival since birth of the
whole group of patients, irrespective of whether a repair
could be performed, is displayed in Figure 1. The estimated
probability to reach the age of 30 years was 58%  7%.
Kaplan-Meier curves of survival after the first operation
were not significantly different for repaired patients and for
those who remained palliated (P .25, log-rank test; Figure
2). After 12 years, the survival of the patients who under-
Figure 3. Freedom from reoperation for right ventricle–to–pulmo-
nary artery conduit replacement.Figure 4. Left major aortopulmonary collateral artery before
The Journal of Thoracicwent a complete repair was 51%  13%. Their chances of
being alive and in class I at 12 years was 32%  10%.
Cox proportional hazards analysis demonstrated that
older age at the time of the first operation taken as a
continuous variable was the only significant but weak factor
predictive of longer late survival for each additional month of
age at the time of the operation (P .02, hazard ratio 0.99).
Eighteen patients had a total of 22 redo procedures for
replacement of the conduit between the right ventricle and
the PA. The first replacement of the conduit was performed
a median of 8 years (range, 4-15 years) after repair. The
freedom from reoperation for conduit replacement is dis-
played in Figure 3. Ten years after repair, the freedom from
reoperation was higher for patients who had a homograft
implanted than for those with a bioprosthetic conduit (85% 
10% vs 43%  11%; P  .04, log-rank test).
Angiographic Studies
A total of 268 angiograms were reviewed. The effects of the
central shunt could be evaluated in 29 patients. Twenty-
three had their main PA directly implanted in the ascending
aorta, and 6 had polytetrafluoroethylene shunts (Gore-Tex
shunt; W. L. Gore & Associates, Inc, Flagstaff, Ariz). One
polytetrafluoroethylene central shunt blocked and all others
promoted growth of the central PAs. Eleven (39%) right and
2 (7%) left PAs showed stenosis of greater than 50%. All of
the PA stenoses occurred in the patients who had a main
pulmonary implantation in the aorta. The left PA diameter
increased from 3  1 to 6  2 mm (P  .001) in the 2-year
interval after shunt completion.
Only 60 unifocalized MAPCAs could be identified on
serial angiograms in 31 patients, an example of which is
given in Figure 4. After a mean of 3.2  4 years, 26 had
thrombosed, and 12 presented with stenosis of greater than
50%. Serial measurements of 29 MAPCAs were obtained.unifocalization (A) and 4 years after unifocalization (B).
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weight of the patients increased from 12  9 to 25  21 kg
(P  .001), the MAPCA size went from 3.6  1 to 4  2
mm (P  .25).
PA patch enlargement could be assessed angiographi-
cally for 21 patched arteries in 14 patients. After a median
of 2.9 years (range, 8 months to 13 years), 4 patched arteries
showed stenosis of greater than 50%. Three were success-
fully dilated, and the fourth patient died of bleeding subse-
quent to the balloon dilatation of the PA.
We collected invasive measurements of RV pressures
obtained during angiography in patients who had undergone
a successful repair. Data were available in 22 patients who
had no RV outflow tract obstruction a median of 1.38 years
(range, 7 days to 9 years) after the repair. The mean ratio
between systolic right and left ventricular pressures was
0.62  0.32. Four patients had suprasystemic RV pres-
sures. Two of these patients died in the month after this
angiogram.
Discussion
Our study set a landmark for the expectations of patients
with pulmonary atresia, VSD, and MAPCA-dependent lung
circulation when offered a multistage approach of multiple
operations aiming toward the completion of a complete
repair. This 20-year work achieved by our predecessors in
Melbourne shows a remarkable improvement in survival
and quality of life among children affected by this condi-
tion. There are not many data concerning survival into
adulthood for these patients. Bull and associates,1 in 1995,
predicted a 20% chance of survival to the age of 30 years.
These results were so disappointing that they wondered
whether surgical intervention did not adversely affect the
outcome of the patients. With a multistage approach, the
chance of survival to the age of 30 years increased to 60%.
Importantly, repair was possible in 65% of the patients.
There seems to be attrition in the number of survivors in the
first few years after repair because of right heart failure in
patients with poorly developed pulmonary vascular bed and
high pulmonary pressures. Nonetheless, we have hope that
survivors of these first years after repair will now have
long-lasting results. All of them now lead active normal
lives. Surgical practice is constantly evolving, and the actual
results should be the standards to which further changes in
practice should be compared.
There has not yet been a consensus on the long-term fate
of the MAPCAs. A study from the Great Ormond Street
Hospital in 1984 raised the suspicion that growth could not
be obtained from MAPCAs.6 The study was based on pro-
cedures performed in an early surgical era, and a lot of the
connections between MAPCAs and native PAs were made
with interposition of prosthetic material. This study did not
dampen the enthusiasm of surgeons to integrate MAPCAs
1500 The Journal of Thoracic and Cardiovascular Surgery ● Decin a newly reconstructed pulmonary circulation, with vari-
ous approaches, techniques, and timing.7-10 Most of the
MAPCA transplantations described in our study were per-
formed through thoracotomies, which seems technically
easier than performing them through sternotomies, by sur-
geons who have proved their technical excellence. Despite
this ideal setting, the results of unifocalization were disap-
pointing. These are technically demanding operations, and
this explains the high rate of thrombosis of these vessels.
But even when the collateral vessels remained patent, they
did not exhibit any growth. Therefore we believe that, at the
time of their transplantation, collateral vessels have already
acquired their maximum development and that their inte-
gration in the pulmonary circulation will not bring any
long-term benefit to the patient because they do not seem to
contribute to the definitive lung circulation of the repaired
patients.
On the other hand, the shunting procedures have been
extremely efficient in developing even diminutive native
pulmonary circulation, and the long-term survival of the
patients and their quality of life seemed to rely mainly on
the growth of the native vessels by these shunting proce-
dures. A high incidence of right PA stenosis was observed
after reimplantation of the main PA in the ascending aorta.
After this procedure, the right PA, tightly applied against
the back of the aorta, might become compressed.
In such a long-term retrospective study, there are natural
limitations. Patients who presented for surgical intervention
were older than those presenting nowadays. Some of them
might represent survivors of a natural selection process.
One could also argue that vessels transplanted sooner
after birth might have better growth potential. However, our
results showed so consistently any lack of growth of the
MAPCAs, that it is difficult for us to believe that an earlier
procedure might result in a potential advantage, especially
given that shunting procedures performed during the same
time frame predisposed to the growth of the native vessels.
On angiography, the identification of a MAPCA is eased
by the recognition of its peculiar morphology, and the
longer the tract of the transplanted MAPCA before it
reaches the lung, the easier its identification. Therefore it is
possible that some MAPCAs transplanted very distally at
the surface of the lung might have a better outcome and
could not be identified.
Finally, it is likely that the patients who were investi-
gated by means of angiography early after repair were those
who were symptomatic. The reported PA pressures were
therefore possibly overestimated.
In conclusion, long-term survival into adulthood of pa-
tients with pulmonary atresia, VSD, and MAPCAs has been
achieved with a multistage approach. In our series, unifo-
calized MAPCAs exhibited a high incidence of occlusion
and no growth. Therefore in patients with pulmonary
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Datresia, VSD, and MAPCAs, operations should aim at
achieving growth of the native PAs by shunting rather
than unifocalization.
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Discussion
Dr Frank L. Hanley (Stanford, Calif). This is an outstanding
article, and I have absolutely no quarrels with your presentation,
data, or research methods. I do have a major difference, however,
with the inferences that you have drawn and where you want to go
in the future.
My comments are designed to explain my reasons for disagree-
ing with your proposed management scheme of this lesion.
Tetralogy of Fallot (TOF)/PA/MAPCAs manifests a wide spec-
trum of pulmonary vascular morphology and physiology, ranging
from patients on the favorable end with normally arborizing true
PAs with the collaterals simply contributing systemic flow into the
PA system to patients on the unfavorable end with completely
absent true PAs and all of the pulmonary blood supply from
collaterals. Most patients fall in the continuum between these 2
extremes, with PAs present but having significant arborization
abnormalities and important segments of lung solely supplied by
collaterals. Any lesion with this degree of variability requires a
carefully formulated management protocol on the basis of mor-
phology and physiology.
The Journal of ThoracicTOF/PA/MAPCAs, in particular, is in great need of such a
protocol. The goal of any protocol is to achieve full repair with the
lowest possible PA pressure in the greatest number of patients. Too
often the recommendation is made simply to place a shunt in
cyanotic patients or to observe growing infants who have adequate
systemic oxygen saturation. These approaches, which are tried and
true for other cyanotic patients who have a single PA compartment
and a single source of pulmonary blood flow, can be disastrous in
a patient with a multicompartmentalized PA vascular system that
yields widely varying pressures and flows in different lung seg-
ments. Contrary to the typical cyanotic patient, a patient with
MAPCAs well balanced on the outside is not necessarily well
balanced on the inside.
The authors are to be congratulated for recognizing the need for
an organized management protocol for this patient population and
for formulating and then proposing such a protocol. They have
presented valuable and credible late follow-up information on a
relatively large series of patients and have done so in a clear and
organized manner. The experience demonstrates a clear improve-
ment on the natural history of this disease and represents an
important historical chapter in the evolution of the thinking as it
relates to the management of TOF/PA/MAPCAS. I respectfully
but strongly disagree, however, with the inferences that the authors
have drawn and thus with the details of their proposed manage-
ment protocol for future patients. The authors have concluded that
surgically bringing collaterals into the PA vascular system has no
benefit. Their reasoning is that unifocalized collaterals commonly
thrombose, and if they stay patent, they do not grow. Thus they
recommend stimulating growth of the true PAs, regardless of the
arborization profile of the PAs or the collateral distribution, using
a surgically placed central shunt. After the PAs enlarge, patients
are evaluated for VSD closure and RV outflow tract conduit
placement. Unifocalization is not included as a central component
of the management plan.
This approach runs counter to all of the principles for promot-
ing a complete and healthy pulmonary vascular bed, which is the
most important criterion in achieving the stated goal of full repair
with low PA pressure. Untouched collateral vessels are exposed to
systemic level pressure and high flow from birth, and they, as well
as the distal lung, begin to degenerate on a time course measured
in weeks to months. By 6 months of age, some lung segments will
be lost to collateral occlusion, and others will be at risk of pulmo-
nary microvascular disease. The result is a limited peripheral
vascular bed that is unhealthy. The approach recommended by the
authors can work well but only in a limited band of patients: those
with a favorable true PA arborization profile. The remainder will
suffer from this approach. This observation is supported by the
outcome data. Fifty-eight percent (49/84) of patients in the au-
thors’ series survived with full repair, and the mean RV/left
ventricular (LV) pressure ratio was 0.62. This mean pressure value
is on the border of what is considered unacceptable hemodynamics
(RV/LV ratio  0.67), and therefore about half of the patients
repaired had an unacceptable result. Thus about 30% of all patients
achieved a hemodynamically acceptable full repair. The median
age at repair was 4 years, and it required 2.6 operations to achieve
full repair.
We also have developed a management protocol for this lesion,
but it differs substantially from that of the authors. Our approach
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tion of achieving unifocalization of all collaterals by the age of 3
to 4 months. The overriding concern is to get all collaterals out of
the high-pressure and flow systemic circulation as soon as possible
and create a 1-compartment pulmonary vascular system. Specific
morphology and physiology dictate the exact approach. In more
than half of all patients, a 1-stage complete unifocalization and
intracardiac repair is performed at 3 to 4 months. In the majority
of the remainder, complete unifocalization is performed, but the
intracardiac repair is deferred until a later time. In a small group of
patients, about 15%, a central aortopulmonary window or a lateral
thoracotomy is performed. Our personal series of 289 total patients
reveals a total of 1069 collaterals. Essentially all collaterals were
unifocalized. Early mortality occurred in 5.1% of patients with
TOF/PA/MAPCAs managed by us from the beginning. In the
typical patient, if we can call it that, the true PAs communicated
with less than half of the lung parenchyma. Our data strongly
indicate that collaterals, when managed appropriately with respect
to timing and technique, do grow and grow well. To emphasize
this point, our subgroup of patients with completely absent true
PAs were reconstructed with only collateral tissue, and this sub-
group has done just as well as the larger group over the long term.
I cite the example of a patient with 4 collaterals and no PAs who
underwent a 1-stage complete unifocalization and intracardiac
repair at 5 months of age. The early postoperative RV/LV ratio
was 0.45. This patient returned for conduit change at age 7½ yrs.
The collateral tissue that solely made up his pulmonary vasculature
had developed in parallel with his somatic growth, and in fact, his
RV/LV ratio was now 0.32. An earlier analysis of our experience
showed that after unifocalization, collateral occlusion is unusual, if
not rare, but about 32% of patients will need an intervention on the
peripheral pulmonary vasculature at 2-year follow up, about the
equivalent follow-up time cited by the authors for their evaluation
of collateral patency.
Most importantly, after this management protocol, a full repair
rate of 83% was achieved. The mean RV/LV ratio was 0.43 (SD
0.13), confirming that the large majority of full repairs were
accompanied by acceptable hemodynamics (ie, an RV/LV ratio 
0.67). Thus about 80% of all cases received a hemodynamically
acceptable full repair at a mean age of 0.6 years for the complete
repairs. In 68% of full repairs, it was accomplished in 1 operation.
The experience described by the authors is an important and
impressive achievement, but it must be placed in the historical
context of the evolution of thinking relating to this disease process
and not used as a basis for formulating new and improved proto-
cols. Current thinking, and the data to back up that thinking,
strongly support moving in a direction opposite that recommended
by the authors. The protocol recommended by the authors going
forward in essence sets the bar too low. It is effective for a very
1502 The Journal of Thoracic and Cardiovascular Surgery ● Declimited subgroup of patients with TOF/PA/MAPCAs but is not de-
signed to achieve the most good for the greatest number of patients.
Therefore, again, I have no quarrel with your data. Mostly, I
would like to understand a little bit better your thinking on why
your proposed management plan is good for the majority of
patients, who will be left with a limited pulmonary vascular bed
after taking this approach.
Dr d’Udekem. Thank you very much. I have to disagree along
several points.
First, I believe that since we have adopted this approach of
shunting all neonates in the first few weeks of life, performing
repeatedly right ventricle–to–PA conduits and abandoning unifo-
calizations, we achieved excellent outcomes, not for part of the
patients but for almost all of them. And we have been very
successful thus far by doing just simple procedures.
The next point concerns what you said about the goal to
achieve, being a repair with the lowest possible PA pressures.
Anybody in the audience, I believe, has mortality for this condition
that varies between 10% and 20% at best. I think that the goal for
these patients is to reduce this mortality to the maximum. We
should have the lowest possible mortality. The London team
showed it 10 years ago, and it is still the same with this historical
series. Procedures and operations kill patients more surely than
their natural history. If we manage to have operations with no
mortality, we will improve the patient’s outcome because we will
improve their survival. I think it is better than achieving repair at
all cost. We had 6 deaths after repair because of pulmonary
hypertension. It is better to have a patient who is alive at 30 or 40
years of age with 85% saturation than dying 2 years after a repair
with 98% saturation.
The next point is the assumption that we will select patients
with a favorable anatomy. I think one of the major mistakes that
has been done in the past, and that is what we believe, is that we
are waiting too long to operate on these patients. And that is a point
of view that you defended in the past. I do not know the numbers
that you quoted today. I know only your publication from 2000, in
which the median age at the first operation was 7 months. And that
was the earliest median age at first operation that appeared in the
literature.
I think that you have to attack these native PAs very early after
birth. The reason why you get these unfavorable anatomies is
because you wait too long. I have reviewed all the angiograms
from this series. All the patients who were operated on before 1
month of age had central PAs. And since we have adopted this new
approach, we did not have patients with no central PAs. We always
have something to put a shunt on.
Dr Williams. Yves, I think in fairness to the final article, we
will interrupt your discussion. We obviously have 2 very strong
points of view, and we will let you sort it out.
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